Anavex, as any investor would know, have conducted a number clinical trials as required to potentially gain approval in humans.
So this lame attempt at rescuing your statement is just another fail.
Regarding below question:
Of course it should, just not as a 'we got this' type proclaimed certainty of success in humans - just as said in my previous post.
Seems you are acting sensibly as in investor yourself. That same attribute should also be reflected as a 'trusted' scientific MB reference to others with less training in critically assessing biotech trials, data and company statements about same.